# A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides

> **NCT07714187** · PHASE1 · NOT_YET_RECRUITING · sponsor: **SecuraBio** · enrollment: 30 (estimated)

## Conditions studied

- Mycosis Fungoides
- Cutaneous T-cell Lymphoma

## Interventions

- **DRUG:** Duvelisib

## Key facts

- **NCT ID:** NCT07714187
- **Lead sponsor:** SecuraBio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01
- **Primary completion:** 2028-10
- **Final completion:** 2029-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07714187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07714187, "A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07714187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*